Using beta-lactam/beta-lactamase inhibitors for infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant Enterobacteriaceae.

Using beta-lactam/beta-lactamase inhibitors for infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant Enterobacteriaceae.

Watkins Richard R; Deresinski Stan

Expert review of anti-infective therapy

2017

2017-10

*Antimicrobial resistance; *beta-lactam/beta-lactamase inhibitors; *blood stream infections; *CRE; *ESBL; Anti-Bacterial Agents/*administration & dosage/pharmacology; beta-Lactam Resistance/drug effects; beta-Lactamase Inhibitors/*administration & dosage/pharmacology; beta-Lactamases/metabolism; beta-Lactams/pharmacology; Carbapenem-Resistant Enterobacteriaceae/drug effects/isolation & purification; Enterobacteriaceae Infections/*drug therapy/microbiology; Enterobacteriaceae/drug effects/isolation & purification; Humans

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

893–895

10

15